美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA207099"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
16571-868-01 16571-868 HUMAN PRESCRIPTION DRUG gabapentin gabapentin CAPSULE ORAL 20220801 N/A ANDA ANDA207099 Rising Pharma Holdings, Inc. GABAPENTIN 300 mg/1 100 CAPSULE in 1 BOTTLE (16571-868-01)
16571-868-03 16571-868 HUMAN PRESCRIPTION DRUG gabapentin gabapentin CAPSULE ORAL 20220801 N/A ANDA ANDA207099 Rising Pharma Holdings, Inc. GABAPENTIN 300 mg/1 30 CAPSULE in 1 BOTTLE (16571-868-03)
16571-868-10 16571-868 HUMAN PRESCRIPTION DRUG gabapentin gabapentin CAPSULE ORAL 20220801 N/A ANDA ANDA207099 Rising Pharma Holdings, Inc. GABAPENTIN 300 mg/1 1000 CAPSULE in 1 BOTTLE (16571-868-10)
16571-868-50 16571-868 HUMAN PRESCRIPTION DRUG gabapentin gabapentin CAPSULE ORAL 20220801 N/A ANDA ANDA207099 Rising Pharma Holdings, Inc. GABAPENTIN 300 mg/1 500 CAPSULE in 1 BOTTLE (16571-868-50)
16571-869-01 16571-869 HUMAN PRESCRIPTION DRUG gabapentin gabapentin CAPSULE ORAL 20220801 N/A ANDA ANDA207099 Rising Pharma Holdings, Inc. GABAPENTIN 400 mg/1 100 CAPSULE in 1 BOTTLE (16571-869-01)
16571-869-03 16571-869 HUMAN PRESCRIPTION DRUG gabapentin gabapentin CAPSULE ORAL 20220801 N/A ANDA ANDA207099 Rising Pharma Holdings, Inc. GABAPENTIN 400 mg/1 30 CAPSULE in 1 BOTTLE (16571-869-03)
16571-869-10 16571-869 HUMAN PRESCRIPTION DRUG gabapentin gabapentin CAPSULE ORAL 20220801 N/A ANDA ANDA207099 Rising Pharma Holdings, Inc. GABAPENTIN 400 mg/1 1000 CAPSULE in 1 BOTTLE (16571-869-10)
16571-869-50 16571-869 HUMAN PRESCRIPTION DRUG gabapentin gabapentin CAPSULE ORAL 20220801 N/A ANDA ANDA207099 Rising Pharma Holdings, Inc. GABAPENTIN 400 mg/1 500 CAPSULE in 1 BOTTLE (16571-869-50)
68788-8546-1 68788-8546 HUMAN PRESCRIPTION DRUG Gabapentin Gabapentin CAPSULE ORAL 20231107 N/A ANDA ANDA207099 Preferred Pharmaceuticals Inc. GABAPENTIN 400 mg/1 100 CAPSULE in 1 BOTTLE (68788-8546-1)
68788-8546-3 68788-8546 HUMAN PRESCRIPTION DRUG Gabapentin Gabapentin CAPSULE ORAL 20231107 N/A ANDA ANDA207099 Preferred Pharmaceuticals Inc. GABAPENTIN 400 mg/1 30 CAPSULE in 1 BOTTLE (68788-8546-3)
68788-8546-6 68788-8546 HUMAN PRESCRIPTION DRUG Gabapentin Gabapentin CAPSULE ORAL 20231107 N/A ANDA ANDA207099 Preferred Pharmaceuticals Inc. GABAPENTIN 400 mg/1 60 CAPSULE in 1 BOTTLE (68788-8546-6)
68788-8546-8 68788-8546 HUMAN PRESCRIPTION DRUG Gabapentin Gabapentin CAPSULE ORAL 20231107 N/A ANDA ANDA207099 Preferred Pharmaceuticals Inc. GABAPENTIN 400 mg/1 120 CAPSULE in 1 BOTTLE (68788-8546-8)
68788-8546-9 68788-8546 HUMAN PRESCRIPTION DRUG Gabapentin Gabapentin CAPSULE ORAL 20231107 N/A ANDA ANDA207099 Preferred Pharmaceuticals Inc. GABAPENTIN 400 mg/1 90 CAPSULE in 1 BOTTLE (68788-8546-9)
42806-509-01 42806-509 HUMAN PRESCRIPTION DRUG Gabapentin Gabapentin CAPSULE ORAL 20170324 N/A ANDA ANDA207099 Epic Pharma, LLC GABAPENTIN 100 mg/1 100 CAPSULE in 1 BOTTLE (42806-509-01)
42806-509-10 42806-509 HUMAN PRESCRIPTION DRUG Gabapentin Gabapentin CAPSULE ORAL 20170324 N/A ANDA ANDA207099 Epic Pharma, LLC GABAPENTIN 100 mg/1 1000 CAPSULE in 1 BOTTLE (42806-509-10)
42806-509-30 42806-509 HUMAN PRESCRIPTION DRUG Gabapentin Gabapentin CAPSULE ORAL 20170324 N/A ANDA ANDA207099 Epic Pharma, LLC GABAPENTIN 100 mg/1 30 CAPSULE in 1 BOTTLE (42806-509-30)
42806-510-01 42806-510 HUMAN PRESCRIPTION DRUG Gabapentin Gabapentin CAPSULE ORAL 20170324 N/A ANDA ANDA207099 Epic Pharma, LLC GABAPENTIN 300 mg/1 100 CAPSULE in 1 BOTTLE (42806-510-01)
42806-510-10 42806-510 HUMAN PRESCRIPTION DRUG Gabapentin Gabapentin CAPSULE ORAL 20170324 N/A ANDA ANDA207099 Epic Pharma, LLC GABAPENTIN 300 mg/1 1000 CAPSULE in 1 BOTTLE (42806-510-10)
42806-510-30 42806-510 HUMAN PRESCRIPTION DRUG Gabapentin Gabapentin CAPSULE ORAL 20170324 N/A ANDA ANDA207099 Epic Pharma, LLC GABAPENTIN 300 mg/1 30 CAPSULE in 1 BOTTLE (42806-510-30)
42806-511-01 42806-511 HUMAN PRESCRIPTION DRUG Gabapentin Gabapentin CAPSULE ORAL 20170324 N/A ANDA ANDA207099 Epic Pharma, LLC GABAPENTIN 400 mg/1 100 CAPSULE in 1 BOTTLE (42806-511-01)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2026 Drugfuture->U.S. FDA National Drug Code DataBase